Inhibition of breast cancer metastasis via PITPNM3 by pachymic acid

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 5, 2012, Pages 1877-1880

  Hong, Ri ^a   Shen, Min He ^b   Xie, Xiao Hong ^a   Ruan, Shan Ming ^b  

^a Department of Breast ^*  (China)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; MDA MB 231; Metastasis; Pachymic acid; PITPNM3

Indexed keywords

BETA CHEMOKINE; CALCIUM BINDING PROTEIN; CCL18 PROTEIN, HUMAN; MEMBRANE PROTEIN; PACHYMIC ACID; PHOSPHOLIPASE A; PITPNM3 PROTEIN, HUMAN; TRITERPENE;

ARTICLE; BREAST TUMOR; CELL MOTION; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HUMAN; METABOLISM; METASTASIS; PHOSPHORYLATION; TUMOR CELL CULTURE; WESTERN BLOTTING; WOUND HEALING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL MOVEMENT; CHEMOKINES, CC; FEMALE; FLOW CYTOMETRY; HUMANS; MEMBRANE PROTEINS; PHOSPHOLIPASES A; PHOSPHORYLATION; TRITERPENES; TUMOR CELLS, CULTURED; WOUND HEALING;

EID: 84872677974     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.5.1877     Document Type: Article

References (13)

1. Chen J, Yao Y, Gong C et al (2011). CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell, 19, 541-55.
2. Clines GA, Guise TA (2005). Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone. Endocr Relat Cancer, 12, 549-83.
3. Fougere M, Gaudineau B, Barbier J et al (2010). NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene. Oncogene, 29, 2292-301.
4. Gapter L, Wang Z, Glinski J, Ng K-y (2005). Induction of apoptosis in prostate cancer cells by pachymic acid from Poria cocos. Biochem Biophys Res Commun, 332, 1153-61.
5. Huang YC, Chang WL, Huang SF, et al (2010). Pachymic acid stimulates glucose uptake through enhanced GLUT4 expression and translocation. Eur J Pharmacol, 648, 39-49.
6. Kaminaga T, Yasukawa K, Kanno H, et al (1996). Inhibitory effects of lanostane-type triterpene acids, the components of Poria cocos, on tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology, 53, 382-5.
7. Lev S, Hernandez J, Martinez R, et al (1999) Identification of a novel family of targets of PYK2 related to Drosophila retinal degeneration B (rdgB) protein. Mol Cell Biol, 19, 2278-88.
8. Martinez FO, Helming L, Gordon S (2009). Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol, 27, 451-83.
9. Mundy GR (2002). Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer, 2, 584-93.
10. Narita D, Seclaman E, Ursoniu S, et al (2011). Expression of CCL18 and interleukin-6 in the plasma of breast cancer patients as compared with benign tumor patients and healthy controls. Rom J Morphol Embryol, 52, 1261-7.
11. Ukiya M, Akihisa T, Tokuda H, et al (2002). Inhibition of tumor-promoting effects by poricoic acids G and H and other lanostane-type triterpenes and cytotoxic activity of poricoic acids A and G from Poria cocos. J Nat Prod, 65, 462-5.
12. Wang X, Lu H, Urvalek AM, et al (2011). KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9. Oncogene, 30, 1901-11.
13. Zohny SF, Fayed ST (2010). Clinical utility of circulating matrix metalloproteinase-7 (MMP-7), CC chemokine ligand 18 (CCL18) and CC chemokine ligand 11 (CCL11) as markers for diagnosis of epithelial ovarian cancer. Med Oncol, 27, 1246-53